Advertisement
UK markets close in 2 hours 57 minutes

  • FTSE 100

    8,022.45
    -1.42 (-0.02%)
     

  • FTSE 250

    19,677.18
    +77.79 (+0.40%)
     

  • AIM

    753.06
    +3.88 (+0.52%)
     

  • GBP/EUR

    1.1616
    +0.0028 (+0.24%)
     

  • GBP/USD

    1.2399
    +0.0048 (+0.39%)
     

  • Bitcoin GBP

    53,284.25
    +87.75 (+0.16%)
     

  • CMC Crypto 200

    1,419.43
    +4.67 (+0.33%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CRUDE OIL

    81.16
    -0.74 (-0.90%)
     

  • GOLD FUTURES

    2,321.10
    -25.30 (-1.08%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • DAX

    18,011.68
    +150.88 (+0.84%)
     

  • CAC 40

    8,065.94
    +25.58 (+0.32%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

Global Uveitis Markets and Competitive Landscape Report 2021-2026

Research and Markets
·2-min read

Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Uveitis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Uveitis Market and Competitive Landscape - 2021, provides comprehensive insights into Uveitis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts Uveitis market size and drug sales. It also provides insights into Uveitis epidemiology and late-stage pipeline.

This research covers the following - Uveitis treatment options, Uveitis late-stage clinical trials pipeline, Uveitis prevalence by countries, Uveitis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global

  • Uveitis pipeline: Find out drugs in clinical trials for the treatment of Uveitis by development phase 3, phase 2, by pharmacological class and company

  • Uveitis epidemiology: Find out the number of patients diagnosed (prevalence) with Uveitis by countries

  • Uveitis drugs: Identify key drugs marketed and prescribed for Uveitis in the US, including trade name, molecule name, and company

  • Uveitis drugs sales: Find out the sales value for Uveitis drugs by countries

  • Uveitis market valuations: Find out the market size for Uveitis drugs in 2020 by countries. Find out how the market advanced from 2018 and forecast to 2026

  • Uveitis drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research:

  • Evaluate commercial market opportunities for Uveitis drugs

  • Synthesize insights for business development & licensing

  • Track market size, competitor drug sales, market shares in Uveitis market

  • Develop in-depth knowledge of competition and markets

  • Analyze Uveitis drug sales data to update your brand planning trackers

  • Develop tactics and strategies to take advantage of opportunities in the market

  • Track Market Events and Trends and analyze key events in Uveitis market

  • Develop forecast models, healthcare frameworks, or economic models

  • Answer key business questions; supports decision making in R&D to long term marketing strategies

ADVERTISEMENT

For more information about this report visit https://www.researchandmarkets.com/r/wuodub

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900